Argon Medical Devices has completed the acquisition of three vascular products from Rex Medical. The OptionELITE retrievable vena cava filter, Cleaner rotational thrombectomy system, and UltraStream chronic haemodialysis catheter are now wholly owned by Argon Medical Devices.
Prior to this transaction, the products were licensed and distributed by Argon through an exclusive agreement with Rex Medical. A company press release says that all three product families have displayed significant growth under Argon’s leadership. The addition of these technologies to Argon Medical’s portfolio “firmly establishes the company’s position as a market leader in the treatment of venous disease,” says Argon.
The OptionELITE is an inferior vena cava filter with US Food and Drug Administration (FDA) clearance for delivery via the popliteal vein, the same access site through which deep vein thrombosis treatment in the legs is commonly initiated.
Cleaner is a wall-contacting rotational thrombectomy system with FDA clearance for use in the peripheral vasculature, and also may be delivered via the popliteal vein to enable filter placement and deep vein thrombosis treatment through a single access site. This technique eliminates significant procedural time compared to other techniques and reduces patient trauma.
The acquisition includes all associated intellectual property related to the three products. “Building on the momentum already established as a licensee of these products, we are further focusing our efforts on the venous disease space, providing safe and effective tools for venous therapy, and strengthening our growth in strategic global markets,” said George A Leondis, president of Argon Medical Devices.